Brainstorm Cell Therapeutics shares owned by Abner, Herrman & BrocK
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Abner, Herrman & BrocK
from 13F filings
Historical chart of Abner, Herrman & BrocK investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by Abner, Herrman & BrocK consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Brainstorm Cell Therapeutics by Abner, Herrman & BrocK
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $82k | 146k | 0.56 |
| 2023-12-31 | $40k | 146k | 0.27 |
| 2023-09-30 | $29k | 146k | 0.20 |
| 2023-06-30 | $577k | 280k | 2.06 |
| 2023-03-31 | $924k | 280k | 3.30 |
| 2022-12-31 | $459k | 280k | 1.64 |
| 2022-09-30 | $1.2M | 280k | 4.42 |
| 2022-06-30 | $731k | 265k | 2.76 |
| 2022-03-31 | $890k | 265k | 3.36 |
| 2021-12-31 | $932k | 233k | 4.00 |
| 2021-09-30 | $676k | 205k | 3.30 |
| 2021-06-30 | $918k | 242k | 3.80 |
| 2021-03-31 | $925k | 242k | 3.83 |
| 2020-12-31 | $1.1M | 242k | 4.53 |
| 2020-09-30 | $4.1M | 241k | 16.92 |
| 2020-06-30 | $2.7M | 239k | 11.21 |
| 2020-03-31 | $260k | 56k | 4.64 |